Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Philip J Devereaux , John Eikelboom Added: 6 years ago
The effect of dabigatran in patients suffering myocardial injury after non-cardiac surgery - ACC 2018 An expert peer-to-peer discussion on the latest data to come out of the MANAGE trial and its implications for clinical practice. Sunday 11th March 2018 @ 11:45 EST ACC.18 Congress, Orlando, FL Discussants: Dr PJ Devereaux (Ontario, US) & Dr John Eikelboom (Ontario, US) Dr PJ… View more
Author(s): Uwe Zeymer Added: 5 months ago
AHA 23 - We are joined on-site by Prof Uwe Zeymer (Klinikum Ludwigshafen, Ludwigshafen, DE) to discuss the findings from a sub-analysis of the ECLS-SHOCK trial.This sub-analysis investigates the impact of cardiac arrest before randomisation on the efficacy of ECLS in patients with infarct-related cardiogenic shock. Investigators enrolled 420 patients with acute MI and cardiogenic shock across 41… View more
Author(s): David E Allie , Chris J Herbert , Craig M Walker Added: 3 years ago
Despite the recent introduction of vascular closure device (VCD) technology, vascular access site complications remain the leading source of morbidity and costs after the approximately eight to eight-and-a-half million percutaneous catheter-based procedures performed annually worldwide.1 VCD trials consistently demonstrate increased patient satisfaction, early ambulation, and decreased hospital… View more
Author(s): John S Rumsfeld , Gregory J Dehmer , Ralph G Brindis Added: 3 years ago
High-quality healthcare is that which increases “the likelihood of desired health outcomes and is consistent with standards of health care.”1 Inherent in such a definition is the critical role of measurement of patient outcomes and the ‘standards of healthcare,’ such as those reflected in evidence-based clinical practice guidelines.2 Unfortunately, when the quality of healthcare in the US is… View more
Author(s): Philip J Devereaux Added: 2 years ago
In this short interview from our coverage of the ACC.22 late-breaking trials, Dr Philip J Devereaux (McMaster University, ON, CA) discusses the POISE-3 trial which was a large international, non-inferiority randomised controlled trial evaluating the efficacy and safety of tranexamic acid (TXA) versus placebo for controlling perioperative bleeding in the noncardiac surgical setting (NCT03505723). … View more
Author(s): Gregory J Dehmer Added: 3 years ago
The use of percutaneous coronary intervention (PCI) for coronary artery revascularization has grown considerably since the first balloon angioplasty in 1977. Improvements in equipment and drug therapies plus the development of coronary artery stents have all contributed to the growth of PCI as an alternative to surgical revascularization. Compared with the early days of balloon angioplasty, when… View more